|
JDP2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.38470000000413E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.003250E-03 |
| Normal-vs-Stage2 |
1.684430E-02 |
| Normal-vs-Stage3 |
9.18060000243415E-08 |
| Normal-vs-Stage4 |
9.242800E-04 |
| Stage1-vs-Stage2 |
8.138000E-01 |
| Stage1-vs-Stage3 |
4.182900E-03 |
| Stage1-vs-Stage4 |
2.226000E-01 |
| Stage2-vs-Stage3 |
2.182300E-02 |
| Stage2-vs-Stage4 |
2.751800E-01 |
| Stage3-vs-Stage4 |
4.583800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.9684999999976E-05 |
| Normal-vs-AfricanAmerican |
1.812160E-01 |
| Normal-vs-Asian |
5.384300E-03 |
| Caucasian-vs-AfricanAmerican |
3.677800E-01 |
| Caucasian-vs-Asian |
6.615400E-01 |
| AfricanAmerican-vs-Asian |
5.481600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.841900E-04 |
| Normal-vs-Female |
3.88970000000377E-05 |
| Male-vs-Female |
9.564600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.563100E-03 |
| Normal-vs-Age(41-60Yrs) |
3.86380000000353E-05 |
| Normal-vs-Age(61-80Yrs) |
1.92560000167319E-08 |
| Normal-vs-Age(81-100Yrs) |
5.045200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.626410E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.744450E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.478400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.842500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.093000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.687000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.5237099999954E-05 |
| Classical-VS-Follicular |
7.868800E-01 |
| Classical-VS-Other |
9.535000E-01 |
| Classical-VS-Normal |
7.183500E-04 |
| Tall-VS-Follicular |
1.982180E-04 |
| Tall-VS-Other |
1.418020E-01 |
| Tall-VS-Normal |
2.09009998197729E-09 |
| Follicular-VS-Other |
8.702800E-01 |
| Follicular-VS-Normal |
6.204600E-04 |
| Other-VS-Normal |
1.776990E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.46160000000528E-05 |
| Normal-vs-N1 |
9.157200E-04 |
| N0-vs-N1 |
8.865000E-01 |
|
|
